期刊文献+

腹腔镜脾脏切除术治疗肝硬化所致脾功能亢进 被引量:8

Study on laparoscopic splenectomy for hypersplenism caused by liver cirrhosis
原文传递
导出
摘要 目的:探讨腹腔镜脾脏切除术治疗肝硬化门脉高压引起的脾功能亢进的临床疗效。方法选取因肝硬化门脉高压引起的脾功能亢进而行脾脏切除术患者38例,其中行开腹脾脏切除术( OS组)18例,行腹腔镜脾脏切除术( LS组)20例。回顾性分析两组手术时间、术中出血量、住院时间、术后T管拔出时间、肝肾功能、血常规、引流液淀粉酶等指标。结果与术前比较,LS组ALT术后2 d内、术后3~6 d均显著降低(t=6.75、9.32,均P<0.05);LS组术后3~6 d AST水平显著降低(t=8.87,P<0.05);LS组术后2 d内、术后3~6 d GGT水平均显著低于术前(t=6.54、10.76,均P<0.05)。 LS组术后BUN下降,与术前差异有统计学意义(t=3.43,P<0.05),术后3~6 d及术后7~9 d,LS组白细胞、血小板及血红蛋白改善均优于OS组(t=19.32、10.21、8.42、6.76、9.32、13.32,均P<0.05)。结论 LS对肝硬化脾脏功能亢进的治疗方面效果更佳,值得推广应用。 Objective To explore the clinical effect of laparoscopic splenectomy caused by liver cirrhosis portal hypertension .Methods 38 patients treated with splenectomy as a result of hypersplenism induced by liver cir-rhosis portal hypertensions were selected .Laparotomy splenectomy was used in 18 cases ( OS group ) , laparoscopic splenectomy was used in 20 cases(LS group).Operation time , amount of bleeding during operation ,duration of hos-pital stays,liver and kidney function,blood routine,AYM were retrospectively analyzed.Results Compared with the preoperative group,LS ALT 2D after operation,postoperative 3-6d were significantly decreased(t=6.75,9.32,all P〈0.05);3-6d AST levels after operation in LS group significantly decreased (t=8.87,P〈0.05);LS group 2D after operation,postoperative 3-6d GGT levels were significantly lower than that of the preoperative (t=6.54,10.76, all P〈0.05);group LS patients urea nitrogen levels falling postoperation ,there was statistically significant difference (t=3.43,P〈0.05),leukocyte levels,PLT and HBG in the two groups increased postoperation ,these were statistical-ly significant difference(t=19.32,10.21,8.42,6.76,9.32,13.32,all P〈0.05),OS group increased more obvious-ly.Conclusion LS has a better treatment effect on hypersplenism caused by liver cirrhosis ,which is worthy of popu-larization and application .
出处 《中国基层医药》 CAS 2014年第14期2109-2111,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 腹腔镜检查 肝硬化 脾机能亢进 门静脉高压 手术治疗 Laparoscopic Liver cirrhosis Hypersplenism Portal hypertension Surgery
  • 相关文献

参考文献15

二级参考文献83

共引文献131

同被引文献47

  • 1姜洪池,赵宪琪.肝硬化门静脉高压症切脾对肝硬化有益还是有害[J].中华肝胆外科杂志,2006,12(9):581-583. 被引量:20
  • 2占小莉,王跃东,叶再元,竺杨文,谢志杰.腹腔镜与开腹肝硬化脾切除肝功能和白细胞变化的比较[J].医学研究杂志,2007,36(1):87-89. 被引量:6
  • 3王卫东,陈小伍,冯剑平,刘清波.腹腔镜脾切除治疗肝硬化脾功能亢进(附6例报告)[J].岭南现代临床外科,2007,7(5):333-334. 被引量:6
  • 4Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: A comparison of the safety of cryoablation and radiofrequency ablation.. European Journal of Radiology, 2014, 83(4):632-638.
  • 5Liu GJ, Ji Q, Moriyasu F, et al. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats.Ultrasound in Medicine and Biology, 2013, 39(11):2158-2165.
  • 6Yeung LWY, Guruge KS, Taniyasu S, et al. Profiles of perfluoroalkyl substances in the liver and serum of patients With liver cancer and cirrhosis in Australia. Ecotoxicology and Environmental Safety, 2013(96):139-146.
  • 7Gu J J, He XH, Li WT, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiologica, 2012, 53(8):862-867.
  • 8Terai S, Takami T, Yamamoto N, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived ceils and mesenchymal cells. Tissue engineering, Part B. Reviews, 2014, 20(3):206-210.
  • 9Zheng G, Zhang LJ, Zhong J, et al. Cerebral blood flow measured by arterial-spin labeling MRI: A useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. European Journal of Radiology, 2013, 82(11):1981-1988.
  • 10于洪量.B超引导下经皮脾穿刺无水乙醇注射治疗脾功能亢进合并门脉高压征的有效性和安全性.医药前沿,2013(4):126-127.

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部